Omnicell, Inc. (OMCL)

NasdaqGS Currently down 0.29 (-0.87%) in today's trading session

1 member of Congress has disclosed 2 trades in Omnicell, Inc. (OMCL) via STOCK Act filings. The most recent disclosure was a sale by Sara Jacobs on 9 April 2021. Aggregate disclosed activity totals roughly $150K in sales (midpoint estimates from bracketed disclosure amounts).

Omnicell, Inc. is currently trading at $33.12, positioned at 16% of its 52-week range ($29.06 – $55.00).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$33.12
24h Change
-0.29 (-0.87%)
52 Week Range
$29.06$55.00
View on NASDAQ

Omnicell, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for OMCL

Select to highlight on chart
1 transactions
Compliance: 50%
Sara Jacobs9 Apr 202128 May 2021SaleStock$50,001 - $100,000N/A

Select transactions to view their annotations on the chart

No overview data available for this stock

Earnings

Next Report

Q3 2026

29 Oct

EPS Est.

$0.42

Rev. Est.

$304.4M

Days Until

62

Recent Quarters

Q2 202630 Jul
EPS$0.94
Beat 101.1%
Q1 202628 Apr
EPS$0.55
Beat 66.7%
Q4 20255 Feb
EPS$0.40
Miss 14.9%
Q3 202530 Oct
EPS$0.51
Beat 41.7%
Q2 202531 Jul
EPS$0.45
Beat 45.2%
Q1 20256 May
EPS$0.26
Beat 62.5%
Q4 20246 Feb
EPS$0.60
Beat 5.3%
Q3 202430 Oct
EPS$0.56
Beat 36.6%
Q2 20241 Aug
EPS$0.51
Beat 218.8%
Q1 20242 May
EPS$0.03
Beat 137.5%
Q4 20238 Feb
EPS$0.33
Beat 94.1%
Q3 20232 Nov
EPS$0.62
Beat 37.8%
Q2 20231 Aug
EPS$0.57
Beat 103.6%
Q1 20232 May
EPS$0.39
Beat 457.1%
Q4 202228 Feb
EPS$0.33
Beat 266.7%
Q3 20222 Nov
EPS$1.00
Beat 6.4%
Q2 20224 Aug
EPS$0.84
Miss 1.2%
Q1 202228 Apr
EPS$0.83
Beat 16.9%
Q4 202114 Feb
EPS$0.92
Miss 3.2%
Q3 20212 Nov
EPS$1.08
Beat 18.7%
Q2 202129 Jul
EPS$0.97
Beat 21.3%
Q1 202129 Apr
EPS$0.83
Beat 23.9%
Q4 20201 Feb
EPS$0.91
Beat 5.8%
Q3 202027 Oct
EPS$0.60
Beat 20.0%
Q2 202028 Jul
EPS$0.37
Miss 13.9%
Q1 20207 May
EPS$0.66
Beat 22.2%
Q4 20196 Feb
EPS$0.77
Miss 1.3%
Q3 201924 Oct
EPS$0.76
Beat 5.6%
Q2 201925 Jul
EPS$0.67
Beat 4.7%
Q1 201925 Apr
EPS$0.61
Beat 48.8%
Q4 20187 Feb
EPS$0.70
Beat 4.5%
Q3 201825 Oct
EPS$0.63
Beat 12.5%
Q2 201826 Jul
EPS$0.46
Beat 15.0%
Q1 201826 Apr
EPS$0.29
Beat 7.4%
Q4 20171 Feb
EPS$0.54
Beat 3.9%
Q3 201726 Oct
EPS$0.42
Beat 2.4%
Q2 201727 Jul
EPS$0.31
Beat 29.2%
Q1 20174 May
EPS$0.06
Beat 200.0%
Q4 201615 Feb
EPS$0.37
Miss 9.8%
Q3 201627 Oct
EPS$0.40
Beat 0.0%
Q2 201628 Jul
EPS$0.38
Beat 18.8%
Q1 201628 Apr
EPS$0.35
Beat 34.6%
Q4 20154 Feb
EPS$0.40
Beat 2.6%
Q3 201529 Oct
EPS$0.36
Beat 0.0%
Q2 201530 Jul
EPS$0.28
Miss 12.5%
Q1 201530 Apr
EPS$0.29
Beat 26.1%
Q4 20143 Feb
EPS$0.39
Beat 18.2%
Q3 201430 Oct
EPS$0.30
Miss 3.2%
Q2 201431 Jul
EPS$0.30
Beat 3.5%
Q1 20141 May
EPS$0.26
Beat 13.0%
Q4 20134 Feb
EPS$0.29
Beat 3.6%
Q3 201331 Oct
EPS$0.31
Beat 14.8%
Q2 20131 Aug
EPS$0.27
Beat 12.5%
Q1 20132 May
EPS$0.21
Beat 10.5%
Q4 201231 Jan
EPS$0.25
Beat 0.0%
Q3 201225 Oct
EPS$0.29
Beat 31.8%
Q2 20121 Aug
EPS$0.20
Beat 11.1%
Q1 20122 May
EPS$0.13
Beat 0.0%
Q4 201126 Jan
EPS$0.19
Beat 18.8%
Q3 201127 Oct
EPS$0.16
Beat 6.7%
Q2 201128 Jul
EPS$0.15
Beat 15.4%
Q1 20112 May
EPS$0.11
Beat 10.0%
Q4 201027 Jan
EPS$0.11
Miss 8.3%
Q3 201027 Oct
EPS$0.11
Beat 10.0%
Q2 201022 Jul
EPS$0.12
Beat 9.1%
Q1 201026 Apr
EPS$0.09
Miss 10.0%
Q4 200928 Jan
EPS$0.11
Beat 10.0%
Q3 200922 Oct
EPS$0.10
Beat 0.0%
Q2 200923 Jul
EPS$0.10
Beat 25.0%
Q1 200930 Apr
EPS$0.07
Beat 40.0%
Q4 200829 Jan
EPS$0.17
Beat 6.3%
Q3 200823 Oct
EPS$0.18
Beat 5.9%
Q2 200821 Jul
EPS$0.17
Beat 6.3%
Q1 200821 Apr
EPS$0.19
Beat 5.6%
Q4 200731 Jan
EPS$0.28
Beat 0.0%
Q3 200718 Oct
EPS$0.27
Beat 8.0%
Q2 200719 Jul
EPS$0.24
Beat 4.3%
Q1 200724 Apr
EPS$0.22
Beat 22.2%
Q4 200630 Jan
EPS$0.19
Beat 11.8%
Q3 200619 Oct
EPS$0.17
Beat 13.3%
Q2 200620 Jul
EPS$0.13
Beat 18.2%
Q1 200620 Apr
EPS$0.10
Beat 25.0%
Q4 200530 Jan
EPS$0.08
Beat 14.3%
Q3 200520 Oct
EPS$0.05
Beat 15.4%
Q2 200521 Jul
EPS$0.00
Q1 200520 Apr
EPS$-0.10
Miss 400.0%
Q4 20043 Feb
EPS$0.10
Miss 33.3%
Q3 200421 Oct
EPS$0.12
Beat 0.0%
Q2 200422 Jul
EPS$0.09
Beat 0.0%
Q1 200414 Apr
EPS$0.08
Beat 14.3%
Q4 200326 Jan
EPS$0.12
Beat 20.0%
Q3 200316 Oct
EPS$0.09
Beat 0.0%
Q2 200317 Jul
EPS$0.08
Beat 60.0%
Q1 200318 Apr
EPS$0.02
Beat 166.7%
Q4 20027 Feb
EPS$-0.12
Miss 33.3%
Q3 200224 Oct
EPS$-0.12
Beat 20.0%
Q2 200230 Jul
EPS$0.08
Beat 33.3%
Q1 200225 Apr
EPS$0.04
Beat 14.3%
Q4 200127 Mar
EPS$0.14
Q4 200129 Jan
EPS$0.06
Beat 200.0%
Q2 200120 Sept
EPS$-0.43
Q4 200031 Mar
EPS$-0.67

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about OMCL

Which members of Congress have traded OMCL?
1 member of Congress has disclosed 2 trade in Omnicell, Inc. (OMCL) under the STOCK Act: Sara Jacobs.
When was OMCL most recently disclosed by Congress?
The most recent OMCL disclosure was a sale by Sara Jacobs on 9 April 2021.
What is the total disclosed congressional trading volume for OMCL?
Members of Congress have disclosed approximately $150K in OMCL sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in OMCL?
This OMCL page updates as soon as new STOCK Act disclosures are filed for Omnicell, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.